Cochrane Abstracts
Interleukin‐1 blocking agents for treating COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐1 Blocking Agents for Treating COVID‐19." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439056/all/Interleukin‐1_blocking_agents_for_treating_COVID‐19.
Interleukin‐1 blocking agents for treating COVID‐19. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439056/all/Interleukin‐1_blocking_agents_for_treating_COVID‐19. Accessed March 26, 2025.
Interleukin‐1 blocking agents for treating COVID‐19. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439056/all/Interleukin‐1_blocking_agents_for_treating_COVID‐19
Interleukin‐1 Blocking Agents for Treating COVID‐19 [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439056/all/Interleukin‐1_blocking_agents_for_treating_COVID‐19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐1 blocking agents for treating COVID‐19
ID - 439056
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439056/all/Interleukin‐1_blocking_agents_for_treating_COVID‐19
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
